期刊文献+

关于半固体制剂中药物的体外释放研究进展 被引量:4

Advances in in vitro drug release from semisolid preparations
下载PDF
导出
摘要 目的综合国内外关于半固体制剂的体外药物释放试验的研究,探讨关于体外药物释放试验各装置特点及试验条件的选择并判断释药模型。方法根据国内外31篇文献,对如何根据所研究半固体制剂的特点选择合适装置及试验条件进行体外药物释放试验进行综述。结果通过药物的体外释放结果判断出药物符合的释药模型并阐明释药机理。结论通过选择合适的试验装置及条件进行体外药物释放试验,根据释药模型阐明释药机理,加深对于半固体制剂体外药物释放的研究。 Objective Based on the study of in vitro drug release test of semisolid preparation at home and abroad,the characteristics of each device and the selection of experimental conditions in vitro drug release test were discussed,and the drug release model was determined.Method According to the characteristics of semisolid preparation,suitable device and experimental conditions were selected for in vitro drug release test.Result According to the results of in vitro drug release test,the drug release model was determined and the mechanism of drug release was elucidated.Conclusion The mechanism of drug release is elucidates according to the model of drug release,and the research on drug release of semisolid preparations in vitro is deepened.
作者 侯迪旭 王东凯 HOU Dixu;WANG Dongkai(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《中国药剂学杂志(网络版)》 2019年第4期135-140,共6页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 体外释放 综述 半固体制剂 扩散池 浸没池 流通池 释药模型 pharmaceutics in vitro release test summary semisolid preparation Franz cell Enhancer cell Flow-through cell drug release model
  • 相关文献

参考文献2

二级参考文献12

  • 1戴伟礼,禹风英,李亦明.三种动物皮肤对外用药物的透皮吸收及其测定[J].中成药,1993,15(3):7-8. 被引量:19
  • 2贝自强.何焕荣治疗心绞痛22例观察[J].中医杂志,1985,26(8):32-33.
  • 3周金泰 黄一帆 雷瑶.兽医透皮治疗体系(TDDS)研究 诺氟沙星擦剂对母猪乳房透皮给药及其临床意义[J].福建农学院学报(自然科学版),:105-108.
  • 4徐君,张晓友.乙氧苯柳胺乳膏治疗限局性皮肤瘙痒病临床观察[J].临床皮肤科杂志.1998(01)
  • 5Stefan Proniuk,Sarah E. Dixon,James Blanchard.Investigation of the Utility of an In Vitro Release Test for Optimizing Semisolid Dosage Forms[J].Pharmaceutical Development and Technology.2001(3)
  • 6Gordon L. Flynn,Vinod P. Shah,Srinivas N. Tenjarla,Michael Corbo,David DeMagistris,Terry G. Feldman,Thomas J. Franz,Deborah R. Miran,David M. Pearce,Joel A. Sequeira,James Swarbrick,Jonas C. T. Wang,Avaraham Yacobi,Joel L. Zatz.Assessment of Value and Applications of In Vitro Testing of Topical Dermatological Drug Products[J].Pharmaceutical Research.1999(9)
  • 7G. A. Van Buskirk,V. P. Shah,D. Adair,H. M. Arbit,S. V. Dighe,M. Fawzi,T. Feldman,G. L. Flynn,M. A. González,V. A. Gray,R. H. Guy,A. K. Herd,S. L. Hem,C. Hoiberg,R. Jerussi,A. S. Kaplan,L. J. Lesko,H. J. Malinowski,N. M. Meltzer,R. L. Nedich,D. M. Pearce,G. Peck,A. Rudman,D. Savello,J. B. Schwartz,P. Schwartz,J. P. Skelly,R. K. Vanderlaan,J. C. T. Wang,N. Weiner,D. R. Winkel,J. L. Zatz.Workshop III Report: Scaleup of Liquid and Semisolid Disperse Systems[J].Pharmaceutical Research.1994(8)
  • 8.Guidance for Industry:SUPAC-SS Nonsterile Dosage Forms,CMC 7[]..1997
  • 9AAPS/FDA Workshop Assessment of value and applications of in vitro testing of topical dermatological drug products . 1997
  • 10Shah V P,Elkins J,Skelly J P.Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams[].Journal of Pharmaceutical Sciences.1992

共引文献4

同被引文献42

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部